Menu Search
Equities

Mevis Medical Solutions AG

  • Add to watchlist
  • Add to portfolio
  • Add an alert
M3V:MUN

Mevis Medical Solutions AG

Actions
  • Price (EUR)24.20
  • Today's Change0.000 / 0.00%
  • Shares traded--
  • 1 Year change-4.35%
  • Beta-0.1266
Data delayed at least 15 minutes, as of Feb 11 2026 07:09 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Mevis Medical Solutions AG is a Germany-based provider of software and services for the medical image processing industry, and offers computer support for image-based medical diagnosis and therapy. The Company develops medical application software for industrial customers including turnkey applications, and also research laboratories. In addition to that, the Company operates an online academy and trains professionals, such as radiologists, in working with its products. The Company's software applications support various applicable imaging modalities, especially magnetic resonance tomography (MRT) and digital mammography, but also computer tomography (CT), tomosynthesis and digital sonography based on ultrasonics.

  • Revenue in EUR (TTM)16.06m
  • Net income in EUR3.17m
  • Incorporated2006
  • Employees102.00
  • Location
    Mevis Medical Solutions AGCaroline-Herschel-Str. 1BREMEN 28359GermanyDEU
  • Phone+49 421224950
  • Fax+49 42 122495999
  • Websitehttps://www.mevis.de/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.